Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colorectal Cancer Post-surgical Therapeutic Effect Assessment and Recurrence Monitoring by Methylated SEPT9

NCT03334890 is registered in ClinicalTrials.gov with BioChain (Beijing) Science and Technology, Inc. as lead sponsor.

NCT NCT03334890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03334890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colorectal Cancer Post-surgical Therapeutic Effect Assessment and Recurrence Monitoring by Methylated SEPT9
Lead sponsor
BioChain (Beijing) Science and Technology, Inc.
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2016
Completion date
December 31, 2017
Enrollment
50 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer